{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:05:53Z","timestamp":1784808353496,"version":"3.55.0"},"reference-count":10,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101015736"],"award-info":[{"award-number":["101015736"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp; Perspec"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The current COVID\u201019 pandemic was an exceptional health situation, including for drug use. As there was no known effective drug for COVID\u201019 at the beginning of the pandemic, different drug candidates were proposed. In this article, we present the challenges for an academic Safety Department to manage the global safety of a European trial during the pandemic. The National Institute for Health and Medical Research (Inserm) conducted a European multicenter, open\u2010label, randomized, controlled trial involving three repurposed and one\u2010in development drugs (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.guidetopharmacology.org\/GRAC\/LigandDisplayForward?ligandId=11504\">lopinavir<\/jats:ext-link>\n                    \/\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.guidetopharmacology.org\/GRAC\/LigandDisplayForward?ligandId=8804\">ritonavir<\/jats:ext-link>\n                    ,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.guidetopharmacology.org\/GRAC\/LigandDisplayForward?ligandId=8339\">IFN\u2010\u03b21a<\/jats:ext-link>\n                    ,\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.guidetopharmacology.org\/GRAC\/LigandDisplayForward?ligandId=7198\">hydroxychloroquine<\/jats:ext-link>\n                    , and\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.guidetopharmacology.org\/GRAC\/LigandDisplayForward?ligandId=10715\">remdesivir<\/jats:ext-link>\n                    ) in adults hospitalized with COVID\u201019. From 25 March 2020 to 29 May 2020, the Inserm Safety Department had to manage 585 Serious Adverse Events (SAEs) initial notification and 396 follow\u2010up reports. The Inserm Safety Department's staff was mobilized to manage these SAEs and to report Expedited safety reports to the competent authorities within the legal timeframes. More than 500 queries were sent to the investigators due to a lack of or incoherent information on SAE forms. At the same time, the investigators were overwhelmed by the management of patients suffering from COVID\u201019 infection. These particular conditions of missing data and lack of accurate description of adverse events made evaluation of the SAEs very difficult, particularly the assessment of the causal role of each investigational medicinal product. In parallel, working difficulties were accentuated by the national lockdown, frequent IT tool dysfunctions, delayed implementation of monitoring and the absence of automatic alerts for SAE form modification. Although COVID\u201019 is a confounding factor per se, the delay in and quality of SAE form completion and the real\u2010time medical analysis by the Inserm Safety Department were major issues in the quick identification of potential safety signals. To conduct a high\u2010quality clinical trial and ensure patient safety, all stakeholders must take their roles and responsibilities.\n                  <\/jats:p>","DOI":"10.1002\/prp2.1072","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:51:05Z","timestamp":1685753465000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of pharmacovigilance during the\n                    <scp>COVID<\/scp>\n                    \u201019 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the\n                    <scp>EU DisCoVeRy<\/scp>\n                    clinical trial"],"prefix":"10.1002","volume":"11","author":[{"given":"No\u00e9mie","family":"Mercier","sequence":"first","affiliation":[{"name":"ANRS, Maladies Infectieuses Emergentes  Paris France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drifa","family":"Belhadi","sequence":"additional","affiliation":[{"name":"AP\u2010HP, H\u00f4pital Bichat, D\u00e9partement d'\u00c9pid\u00e9miologie, Biostatistique et Recherche Clinique  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"DeChanet","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Inserm CIC 1414 and Rennes University Hospital  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Delmas","sequence":"additional","affiliation":[{"name":"Institut de Sant\u00e9 Publique, P\u00f4le Recherche Clinique, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Saillard","sequence":"additional","affiliation":[{"name":"ANRS, Maladies Infectieuses Emergentes  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Dumousseaux","sequence":"additional","affiliation":[{"name":"Institut de Sant\u00e9 Publique, P\u00f4le Recherche Clinique, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soizic","family":"Le\u00a0Mestre","sequence":"additional","affiliation":[{"name":"ANRS, Maladies Infectieuses Emergentes  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fougerou\u2010Leurent","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Inserm CIC 1414 and Rennes University Hospital  Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Ferrane","sequence":"additional","affiliation":[{"name":"Institut de Sant\u00e9 Publique, P\u00f4le Recherche Clinique, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Burdet","sequence":"additional","affiliation":[{"name":"AP\u2010HP, H\u00f4pital Bichat, D\u00e9partement d'\u00c9pid\u00e9miologie, Biostatistique et Recherche Clinique  Paris France"},{"name":"AP\u2010HP, H\u00f4pital Bichat Unit\u00e9 de Recherche Clinique  Paris France"},{"name":"Universit\u00e9 de Paris, IAME, INSERM  Paris France"},{"name":"AP\u2010HP, H\u00f4pital Bichat D\u00e9partement d'\u00c9pid\u00e9miologie, Biostatistique et Recherche Clinique  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Esp\u00e9rou","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon D\u00e9partement des Maladies Infectieuses et Tropicales  Lyon France"},{"name":"Centre International de Recherche en Infectiologie (CIRI) Inserm 1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, \u00c9cole Normale Sup\u00e9rieure de Lyon, Univ Lyon  Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Hites","sequence":"additional","affiliation":[{"name":"L'H\u00f4pital Universitaire de Bruxelles\u2010H\u00f4pital \u00c9rasme Universit\u00e9 Libre de Bruxelles, Clinique des Maladies Infectieuses  Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Peiffer\u2010Smadja","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris, IAME, INSERM  Paris France"},{"name":"AP\u2010HP, H\u00f4pital Bichat, Service de Maladies Infectieuses et Tropicales  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Poissy","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lille, Inserm U1285, CHU Lille, P\u00f4le de R\u00e9animation CNRS, UMR 8576 \u2010 UGSF \u2010 Unit\u00e9 de Glycobiologie Structurale et Fonctionnelle  Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Andrejak","sequence":"additional","affiliation":[{"name":"CHU d'Amiens, D\u00e9partement de Pneumologie UR4294 AGIR Picardie Jules Verne University  Amiens France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Artur","family":"Paiva","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Diagnostic and Public Health University of Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Staub","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Luxembourg, Maladies Infectieuses  Luxembourg City Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Greil","sequence":"additional","affiliation":[{"name":"Paracelsus Medical University Salzburg Laboratory of Immunological and Molecular Cancer Research  Salzburg Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Institut Pierre\u2010Louis d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Mentre","sequence":"additional","affiliation":[{"name":"AP\u2010HP, H\u00f4pital Bichat, D\u00e9partement d'\u00c9pid\u00e9miologie, Biostatistique et Recherche Clinique  Paris France"},{"name":"AP\u2010HP, H\u00f4pital Bichat Unit\u00e9 de Recherche Clinique  Paris France"},{"name":"Universit\u00e9 de Paris, IAME, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"ANRS, Maladies Infectieuses Emergentes  Paris France"},{"name":"Universit\u00e9 de Paris, IAME, INSERM  Paris France"},{"name":"AP\u2010HP, H\u00f4pital Bichat, Service de Maladies Infectieuses et Tropicales  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9642-0584","authenticated-orcid":false,"given":"Alpha","family":"Diallo","sequence":"additional","affiliation":[{"name":"ANRS, Maladies Infectieuses Emergentes  Paris France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, INSERM  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DisCoVeRy Safety Working group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_12_4_1","unstructured":"World Health Organization.Coronavirus disease (COVID\u201019). Technical guidance.2020https:\/\/www.who.int\/fr\/emergencies\/diseases\/novel\u2010coronavirus\u20102019\/technical\u2010guidance\/naming\u2010the\u2010coronavirus\u2010disease\u2010(covid\u20102019)\u2010and\u2010the\u2010virus\u2010that\u2010causes\u2010it 30 Nov 2020"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.012658"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03011-14"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa350"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0156-0"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041437"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.1072","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/prp2.1072","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.1072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:51:06Z","timestamp":1784807466000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.1072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1002\/prp2.1072"],"URL":"https:\/\/doi.org\/10.1002\/prp2.1072","archive":["Portico"],"relation":{},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"value":"2052-1707","type":"print"},{"value":"2052-1707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2022-11-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01072"}}